β-caryophyllene oxide (CAO), α-humulene (HUM), trans-nerolidol (NER) and valencene (VAL) are constituents of the essential oil of Myrica rubra (MEO), which has significant antiproliferative effect in various cancer cell lines. In the present study, we compared the antiproliferative effect of these sesquiterpenes alone and in combination with the cytostatic drug doxorubicin (DOX) in cancer cell lines with different sensitivity to DOX. Two ovarian cancer cell lines (sensitive A2780 and partly resistant SKOV3) and two lymphoblast cancer cell lines (sensitive CCRF/CEM and completely resistant CEM/ADR) were used. The observed effects varied among sesquiterpenes and also differed in individual cell lines, with only VAL being effective in all the cell lines. A strong synergism of DOX with NER was found in the A2780 cells, while DOX acted synergistically with HUM and CAO in the SKOV3 cells. In the CCRF/CEM cells, a synergism of DOX with CAO and NER was observed. In resistant CEM/ADR cells, sesquiterpenes did not increase DOX efficacy, although they significantly increased accumulation of DOX (up to 10-times) and rhodamine-123 (substrate of efflux transporter ABCB1) within cancer cells. In conclusion, the tested sesquiterpenes were able to improve DOX efficacy in the sensitive and partly resistant cancer cells, but not in cells completely resistant to DOX.

Department of Biochemical Sciences Faculty of Pharmacy Charles University Heyrovského 1203 50005 Hradec Králové Czech Republic

Department of Chemistry Faculty of Science University of Hradec Králové Hradecká 1285 50003 Hradec Králové Czech Republic

Zobrazit více v PubMed

Konig G.M., Wright A.D. New and unusual sesquiterpenes: Kelsoene, prespatane, epi-gamma-gurjunene, and t-cadinthiol, from the tropical marine sponge cymbastela hooperi. J. Org. Chem. 1997;62:3837–3840. doi: 10.1021/jo970015o. DOI

Ayer W.A., Browne L.M. Terpenoid metabolites of mushrooms and related basidiomycetes. Tetrahedron. 1981;37:2199–2248. doi: 10.1016/S0040-4020(01)97979-7. DOI

Finefield J.M., Sherman D.H., Kreitman M., Williams R.M. Enantiomeric natural products: Occurrence and biogenesis. Angew. Chem. 2012;51:4802–4836. doi: 10.1002/anie.201107204. PubMed DOI PMC

Bartikova H., Hanusova V., Skalova L., Ambroz M., Bousova I. Antioxidant, pro-oxidant and other biological activities of sesquiterpenes. Curr. Top. Med. Chem. 2014;14:2478–2494. doi: 10.2174/1568026614666141203120833. PubMed DOI

Yang B., Zhao Y.P., Lou C.H., Zhao H.J. Eupalinolide O, a novel sesquiterpene lactone from Eupatorium lindleyanum DC., induces cell cycle arrest and apoptosis in human MDA-MB-468 breast cancer cells. Oncol. Rep. 2016;36:2807–2813. doi: 10.3892/or.2016.5115. PubMed DOI

Wang J., Cui L., Feng L., Zhang Z.H., Song J., Liu D., Jia X.B. Isoalantolactone inhibits the migration and invasion of human breast cancer MDA-MB-231 cells via suppression of the p38 MAPK/NF-kB signaling pathway. Oncol. Rep. 2016;36:1269–1276. doi: 10.3892/or.2016.4954. PubMed DOI

Li H.Y., Li M.M., Wang G.C., Shao F.Y., Chen W.B., Xia C., Wang S., Li Y.L., Zhou G.X., Liu Z. EM23, a natural sesquiterpene lactone from elephantopus mollis, induces apoptosis in human myeloid leukemia cells through thioredoxin- and reactive oxygen species-mediated signaling pathways. Front Pharmacol. 2016;7:77. doi: 10.3389/fphar.2016.00077. PubMed DOI PMC

Van Haaften C., Boot A., Corver W.E., van Eendenburg J.D.H., Trimbos B.J.M.Z., van Wezel T. Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells. J. Exp. Clin. Cancer Res. 2015;34:38. doi: 10.1186/s13046-015-0157-2. PubMed DOI PMC

Quinn B.A., Dash R., Sarkar S., Azab B., Bhoopathi P., Das S.K., Emdad L., Wei J., Pellecchia M., Sarkar D., et al. Pancreatic cancer combination therapy using a BH3 mimetic and a synthetic tetracycline. Cancer Res. 2015;75:2305–2315. doi: 10.1158/0008-5472.CAN-14-3013. PubMed DOI PMC

Li X.Q., Lin Z.H., Zhang B., Guo L., Liu S., Li H., Zhang J.B., Ye Q.H. Beta-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1. Sci. Rep. 2016;6:21010. doi: 10.1038/srep21010. PubMed DOI PMC

Ambroz M., Bousova I., Skarka A., Hanusova V., Kralova V., Matouskova P., Szotakova B., Skalova L. The influence of sesquiterpenes from Myrica rubra on the antiproliferative and pro-oxidative effects of doxorubicin and its accumulation in cancer cells. Molecules. 2015;20:15343–15358. doi: 10.3390/molecules200815343. PubMed DOI PMC

Pillozzi S., Masselli M., de Lorenzo E., Accordi B., Cilia E., Crociani O., Amedei A., Veltroni M., D’Amico M., Basso G., et al. Chemotherapy resistance in acute lymphoblastic leukemia requires herg1 channels and is overcome by herg1 blockers. Blood. 2011;117:902–914. doi: 10.1182/blood-2010-01-262691. PubMed DOI

Mullighan C.G., Su X., Zhang J., Radtke I., Phillips L.A., Miller C.B., Ma J., Liu W., Cheng C., Schulman B.A., et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N. Engl. J. Med. 2009;360:470–480. doi: 10.1056/NEJMoa0808253. PubMed DOI PMC

Housman G., Byler S., Heerboth S., Lapinska K., Longacre M., Snyder N., Sarkar S. Drug resistance in cancer: An overview. Cancers. 2014;6:1769–1792. doi: 10.3390/cancers6031769. PubMed DOI PMC

Thorn C.F., Oshiro C., Marsh S., Hernandez-Boussard T., McLeod H., Klein T.E., Altman R.B. Doxorubicin pathways: Pharmacodynamics and adverse effects. Pharm. Genom. 2011;21:440–446. doi: 10.1097/FPC.0b013e32833ffb56. PubMed DOI PMC

Hill C.R., Jamieson D., Thomas H.D., Brown C.D., Boddy A.V., Veal G.J. Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo. Biochem. Pharmacol. 2013;85:29–37. doi: 10.1016/j.bcp.2012.10.004. PubMed DOI PMC

Langhansova L., Hanusova V., Rezek J., Stohanslova B., Ambroz M., Kralova V., Vanek T., Lou J.D., Yun Z.L., Yang J., et al. Essential oil from Myrica rubra leaves inhibits cancer cell proliferation and induces apoptosis in several human intestinal lines. Ind. Crop. Prod. 2014;59:20–26. doi: 10.1016/j.indcrop.2014.04.018. DOI

Ambroz M., Hanusova V., Skarka A., Bousova I., Kralova V., Langhasova L., Skalova L. Essential oil from Myrica rubra leaves potentiated antiproliferative and prooxidative effect of doxorubicin and its accumulation in intestinal cancer cells. Planta Med. 2016;82:89–96. doi: 10.1055/s-0035-1558083. PubMed DOI

Barla A., Topcu G., Oksuz S., Tumen G., Kingston D.G.I. Identification of cytotoxic sesquiterpenes from Laurus nobilis L. Food Chem. 2007;104:1478–1484. doi: 10.1016/j.foodchem.2007.02.019. DOI

Saab A.M., Guerrini A., Sacchetti G., Maietti S., Zeino M., Arend J., Gambari R., Bernardi F., Efferth T. Phytochemical analysis and cytotoxicity towards multidrug-resistant leukemia cells of essential oils derived from lebanese medicinal plants. Planta Med. 2012;78:1927–1931. doi: 10.1055/s-0032-1327896. PubMed DOI

Chou T.C. Drug combination studies and their synergy quantification using the chou-talalay method. Cancer Res. 2010;70:440–446. doi: 10.1158/0008-5472.CAN-09-1947. PubMed DOI

Morimoto H., Yonehara S., Bonavida B. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-fas antibody and drugs or toxins. Cancer Res. 1993;53:2591–2596. PubMed

Kartner N., Riordan J.R., Ling V. Cell surface p-glycoprotein associated with multidrug resistance in mammalian cell lines. Science. 1983;221:1285–1288. doi: 10.1126/science.6137059. PubMed DOI

Morimoto H., Safrit J.T., Bonavida B. Synergistic effect of tumor necrosis factor-alpha- and diphtheria toxin-mediated cytotoxicity in sensitive and resistant human ovarian tumor cell lines. J. Immunol. 1991;147:2609–2616. PubMed

Silva R., Vilas-Boas V., Carmo H., Dinis-Oliveira R.J., Carvalho F., Bastos M.D., Remiao F. Modulation of p-glycoprotein efflux pump: Induction and activation as a therapeutic strategy. Pharmacol. Ther. 2015;149:1–123. doi: 10.1016/j.pharmthera.2014.11.013. PubMed DOI

Wu Q., Yang Z.P., Nie Y.Z., Shi Y.Q., Fan D.M. Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches. Cancer Lett. 2014;347:159–166. doi: 10.1016/j.canlet.2014.03.013. PubMed DOI

Abdallah H.M., Al-Abd A.M., El-Dine R.S., El-Halawany A.M. P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review. J. Adv. Res. 2015;6:45–62. doi: 10.1016/j.jare.2014.11.008. PubMed DOI PMC

Skarka A., Skarydova L., Stambergova H., Wsol V. Anthracyclines and their metabolism in human liver microsomes and the participation of the new microsomal carbonyl reductase. Chem. Biol. Interact. 2011;191:66–74. doi: 10.1016/j.cbi.2010.12.016. PubMed DOI